Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-21

Study Completion Date

2023-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refractory MP for 6 months. Secondary outcomes were to identify the clinical and diagnostic features of the MP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulsed Radiofrequency Treatment in Lumbar Facet-Related Pain

NCT06157294

Facet Joint Pain Pain Syndrome Pain, Chronic

COMPLETED NA

Effect of Pulsed Magnetic Therapy Versus Phonophoresis in Discogenic Lumbar Radiculopathy Patients

NCT06296303

Lumbar Radiculopathy

NOT_YET_RECRUITING NA

Pulsed Radiofrequency Treatment Of the Gasserian Ganglion for tRigeminal nEuralgia: a retroSpective Study

NCT06174818

Trigeminal Neuralgia (TN)

COMPLETED

Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain

NCT06185816

Pain, Nerve

NOT_YET_RECRUITING PHASE2/PHASE3

Pulsed Electromagnetic Field Therapy for Neuropathic Pain in Lumbar Disc Herniation

NCT07263737

Lumbar Disc Herniation With Radiculopathy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refractory MP for 6 months. Secondary outcomes were to identify the clinical and diagnostic features of the MP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meralgia Paresthetica

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

patients treated with PRFT

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* older than 18 years treated with PRF neuromodulation of LFCN for MP
* followed up at least 6 months in the pain clinic of the tertiary hospital between January 2020 and August 2023.

Exclusion Criteria

* inadequate follow-up or missing documentation
* If a new analgesic drug was prescribed during the follow-up period that could affect the evaluation of outcomes, the patients were also excluded.
* Patients who missed appointments, or were unable to communicate with; were not included in the study.
* Patients with secondary entrapment neuropathy (e.g., diabetes, inflammatory arthritis, hypothyroidism), malignancy, pregnancy, skin infection in the inguinal region or dermatitis, lumbar radiculopathy, polyneuropathy, and cardiac pacemakers were excluded.
* In the SSEP analysis, when the latency of LFCN was not evaluated in both sides, these patients were not also included in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No